Recent Quotes (30 days)

You have no recent quotes
chg | %

Helix Biopharma Corp.  

(Public, TSE:HBP)   Watch this stock  
Find more results for HBP
0.00 (0.00%)
Jan 30 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.50 - 1.50
52 week 1.30 - 2.40
Open 1.50
Vol / Avg. 100.00/1,547.00
Mkt cap 113.85M
P/E     -
Div/yield     -
EPS -0.12
Shares 75.90M
Beta 0.31
Inst. own 0%
Mar 30, 2015
Q2 2015 Helix Biopharma Corp Earnings Release (Estimated) Add to calendar
Dec 15, 2014
Q1 2015 Helix Biopharma Corp Earnings Release

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -126.78% -126.55%
Return on average equity -146.94% -148.02%
Employees 12 -
CDP Score - -


305 Industrial Pky S
+1-905-8412300 (Phone)
+1-905-8412244 (Fax)

Website links


Helix BioPharma Corp. (Helix) is a biopharmaceutical company focused on cancer therapy. Helix is developing products for the treatment and prevention of cancer based on its technologies. The Company�s product development initiatives have focused on its L-DOS47 and Topical Interferon Alpha-2b new drug candidates. As of July 31, 2012, the Company derived its revenue from distribution in Canada from Klean-Prep1, Orthovisc1, Monovisc1, Immunovir1 and Normacol1. The Company has a profitable distribution business in Canada. The products distributed in Canada include Orthovisc and Monovisc, treatments for osteoarthritis of the knee; Klean-Prep and Normacol, gastrointestinal products, and Imunovir, an immune system modulating drug. During the fiscal year ended July 31, 2012 (fiscal 2012), its product revenue derived mainly from the sale in Canada of Klean-Prep, Orthovisc and Monovisc. In August 2013, Helix BioPharma Corp established a Polish subsidiary (Helix Polska).

Officers and directors

Yvon Bastien Independent Chairman of the Board
Age: 66
Robert A. Verhagen President, Chief Executive Officer, Director
Age: 44
Photios Michalargias Chief Financial Officer
Age: 50
Heman Chao Ph.D. Chief Scientific Officer
Age: 51
Sylwester Cacek Director
Slawomir Majewski M.D. Independent Director
Age: 57
Marek Orlowski Independent Director
Age: 45
Sven Rohmann Independent Director
Age: 51
Stacy L. Wills Independent Director
Age: 44